Online citations, reference lists, and bibliographies.
← Back to Search

Mesothelioma Trends In The United States: An Update Based On Surveillance, Epidemiology, And End Results Program Data For 1973 Through 2003.

B. Price, A. Ware
Published 2004 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Using 1973-2000 mesothelioma incidence data released by the Surveillance, Epidemiology, and End Results Program in April 2003, the authors estimated the parameters of a birth-cohort and age model to determine whether previously reported patterns of mesothelioma in the United States have changed. Compared with analyses based on data through 1992, a slower decline was found in male cases immediately after a peak in 2000-2004, but no other notable changes in the time pattern were detected. Analysis confirmed that the annual number of male mesothelioma cases, which increased steeply from the 1970s through the mid-1990s, has leveled off in terms of both the age-adjusted rate and the absolute numbers of cases. After a peak of approximately 2,000 cases, a return to background levels is expected by 2055. The total projected number of male mesothelioma cases in 2003-2054 is approximately 71,000. The maximum lifetime risk for males, which occurs for the 1925-1929 birth cohort, is 1.8 x 10(-3). The age-adjusted rate for females is constant, as are the female lifetime mesothelioma risk across birth cohorts (3.6 x 10(-4)) and the annual risk (3.9 x 10(-6)). The time pattern of cases for females supports the existence of a threshold exposure for mesothelioma and a quantifiable background rate.
This paper references
10.1097/00000478-199405000-00002
Deciduoid Peritoneal Mesothelioma: An Unusual Phenotype Affecting Young Females
A. Nascimento (1994)
10.1136/oem.60.1.50
Update of predictions of mortality from pleural mesothelioma in the Netherlands
O. Segura (2003)
10.1097/00000478-198501000-00012
Diffuse malignant peritoneal mesothelioma in a 13-year-old girl. Report of a case and review of the literature.
A. Talerman (1985)
10.1093/JNCI/95.1.38
Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines.
H. Strickler (2003)
10.1097/00000478-200010000-00021
Deciduoid epithelial mesothelioma of the pleura with focal rhabdoid change.
L. Puttagunta (2000)
10.1159/000029549
Deciduoid Pleural Mesothelioma Affecting a Young Female without Prior Asbestos Exposure
K. Gloeckner-Hofmann (2000)
10.1002/1097-0142(19840901)54:5<951::AID-CNCR2820540536>3.0.CO;2-A
Non‐asbestos‐related malignant mesothelioma. A review
J. T. Peterson (1984)
10.1007/s004280050339
Epithelial mesothelioma with deciduoid features
Z. Orosz (1999)
10.1093/OXFORDJOURNALS.AJE.A009093
Analysis of current trends in United States mesothelioma incidence.
B. Price (1997)
10.1136/BMJ.326.7404.1417-B
Annual deaths from mesothelioma in Britain to reach 2000 by 2010
C. White (2003)
10.1097/00000478-200002000-00015
Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females.
J. Shanks (2000)
IMMUNIZATION SAFETY REVIEW COMMITTEE
K. Stratton (2002)
10.1002/(SICI)1097-4652(199908)180:2<167::AID-JCP4>3.0.CO;2-Q
New molecular and epidemiological issues in mesothelioma: Role of SV40
M. Carbone (1999)
Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer
K. Stratton (2002)
10.1016/c2009-0-03129-8
Asbestos and Disease
I. J. Selikoff (1978)
10.1002/DC.10068
Primary epithelial malignant mesothelioma of the pericardium with deciduoid features: Cytohistologic and immunohistochemical study
J. Reis-Filho (2002)
10.1046/j.1365-2559.2002.01373.x
Malignant deciduoid mesothelioma of the pleura: report of two cases with long survival
G. Serio (2002)
10.1097/00000478-200104000-00026
Deciduoid mesothelioma of the pleura after radiation therapy for Hodgkin's disease presenting as a mediastinal mass.
J. Henley (2001)
10.1136/oem.51.12.804
Malignant mesothelioma: attributable risk of asbestos exposure.
R. Spirtas (1994)
10.1023/A:1009685507602
Estimating Lifetime and Age-Conditional Probabilities of Developing Cancer
L. Wun (1998)
10.1002/ijc.10806
Mesothelioma incidence seems to have leveled off in Sweden
K. Hemminki (2003)
Report of a Case and Review of the Literature
F. Franchir (1981)
10.1002/cncr.10209
Diffuse malignant epithelial mesotheliomas of the peritoneum in women
S. Kerrigan (2002)
10.1097/00000478-200006000-00006
Epithelial mesothelioma with deciduoid features: report of four cases.
N. Ordóñez (2000)
Revised birth and fertility rates for the United States, 2000 and 2001.
S. Ventura (2003)



This paper is referenced by
10.1007/s00761-009-1576-5
Peritoneales Mesotheliom – ein seltener Tumor der Bauchhöhle
A. Tannapfel (2009)
10.1002/pbc.21718
Treatment of peritoneal mesothelioma in pediatric patients
L. Cioffredi (2009)
10.3109/10408444.2012.709821
Evaluation of take home (para-occupational) exposure to asbestos and disease: a review of the literature
E. Donovan (2012)
10.1038/sj.bjc.6602307
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050
J. Hodgson (2005)
Wczesne i odległe wyniki leczenia złośliwego międzybłoniaka opłucnej na podstawie analizy 170 przypadków
Bryl Maciej (2012)
10.1111/risa.13312
Potential Airborne Asbestos Exposure and Risk Associated with the Historical Use of Cosmetic Talcum Powder Products.
A. Burns (2019)
10.1201/B10958-2
The History of Asbestos Utilization and Recognition of Asbestos-Induced Diseases
D. Henderson (2011)
10.21037/jtd.2016.03.92
Localized malignant pleural sarcomatoid mesothelioma misdiagnosed as benign localized fibrous tumor.
Kwan-Chang Kim (2016)
10.1179/oeh.2009.15.2.166
Mesothelioma Risk and Environmental Exposure to Asbestos: Past and Future Trends in Japan
K. Azuma (2009)
10.2486/INDHEALTH.45.379
Malignant mesothelioma: global incidence and relationship with asbestos.
C. Bianchi (2007)
10.3892/OL_00000104
Potassium octatitanate fibers (TISMO) induce pleural mesothelial cell reactions with iron accumulation in female A/J mice.
M. Yokohira (2010)
10.1016/J.JSS.2007.03.048
The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
J. Stewart (2007)
10.1120/jacmp.v9i4.2799
Compensator‐based intensity‐modulated radiation therapy for malignant pleural mesothelioma post extrapleural pneumonectomy
K. Javedan (2008)
10.1016/j.lungcan.2008.08.013
Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent.
G. Cartenì (2009)
CHEST IMAGING Thoracic Computed Tomography Findings in Malignant Mesothelioma
Omer Tamer Doğan (2012)
10.1371/journal.pone.0030221
Identification of miRNA-103 in the Cellular Fraction of Human Peripheral Blood as a Potential Biomarker for Malignant Mesothelioma – A Pilot Study
D. Weber (2012)
10.3978/j.issn.2225-319X.2012.11.04
Malignant pleural mesothelioma: an epidemiological perspective.
Benjamin M. Robinson (2012)
Clinical Outcome Normal Pleura and Predict Lung Asbestos Burden and Epigenetic Profiles Distinguish Pleural Mesothelioma from Updated
B. Christensen (2008)
10.3747/CO.2007.132
Phase II testing of sunitinib: the National Cancer Institute of Canada Clinical Trials Group IND Program Trials IND.182–185
R. Buckstein (2007)
10.1007/BF03256303
Biomarkers for Malignant Pleural Mesothelioma
L. Greillier (2012)
10.3109/10408444.2010.508162
Benzene and human health: A historical review and appraisal of associations with various diseases
D. Galbraith (2010)
10.1111/crj.12069
Other causative factors for lung diseases in populations exposed to asbestos
J. H. Lange (2014)
10.3816/CLC.2009.n.033
Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
Brad E Wilcox (2009)
10.1111/php.13065
A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma
S. Rice (2019)
10.1016/J.JTCVS.2004.10.034
Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.
J. Erasmus (2005)
10.1080/01913120500313168
Biologic, Cytogenetic, and Molecular Factors in Mesothelial Proliferations
J. Hicks (2006)
10.1016/j.lungcan.2013.05.014
The role of epigenetics in malignant pleural mesothelioma.
Fabian Vandermeers (2013)
10.1200/JCO.2007.15.2868
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
G. Simon (2008)
10.1097/RLI.0b013e3181817b3d
Computed Tomography, Positron Emission Tomography, Positron Emission Tomography/Computed Tomography, and Magnetic Resonance Imaging for Staging of Limited Pleural Mesothelioma: Initial Results
C. Plathow (2008)
Malignant mesothelioma mortality--United States, 1999-2005.
K. M. Bang (2009)
10.1007/s00063-009-1162-z
Versicherungsmedizinische Aspekte bei peritonealen Mesotheliomen und sonstigen peritonealen Tumoren
Volker Neumann (2009)
10.2486/INDHEALTH.MS1147
Malignant mesothelioma: a clinical study of 238 cases.
Steven E. Haber (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar